BakerHostetler represented Pulse Biosciences in its public rights offering. Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky represented P10 in the transaction, while Davis Polk advised the representatives of the several underwriters. P10, Inc., a leading private markets solutions provider, announced...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky represented Saba Capital Management in the transaction. Saba Capital Management, L.P. completed its proxy fight against Templeton Global Income Fund (NYSE: GIM). Shareholders...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP represented Summit Therapeutics in the offering. Summit Therapeutics Inc. (NASDAQ: SMMT) executed its rights offering of up to 14,312,977 shares of its...
You must be a Standard 1 Year member to access this content.
